The Venture Capital Funds of

1. The Venture Capital Funds of Giovanni De Caro

2. The Value Chain Mature Companies – pre-IPO, LBO, replacement Early Stage – 1° round and follow on round Late Stage - Expansion Angel Investing Seed Atlante Seed

3. Our Investment Committee External Members Leaders in Technology and Innovation Transfer Alberto Sangiovanni Vincentelli Professor, Berkeley founding partner, Cadence and Synopsys Elizabeth Robinson President, Nicox Research Institute Claudio Carnevale CEO founder of Acotel Group Catia Bastioli CEO, Novamont

4. We also have an Advisory Board with strong competence in main technology areas Biotech & Pharma Alessandro Noseda • Chief Scientific Officer Sigma Tau SpA • CEO Sigma Tau Research Switzerland SA Alessandro Quattrone • Associate Professor of Applied Biology @ University of Trento Medtech Luigi Satragno • Managing Director R&D and Strategic Marketing @ Esaote Cleantech Luigi Capuzzi • Director R&D @ Novamont ICT Matteo Colombo • Manager of R&D office at Intesa Sanpaolo Group Services

5. Our Portfolios Atlante Seed 5

6. Main characteristics Size Euro 25 Mln completely subscribed by IMI Investimenti S.p.A. Start 2008 Duration 12 years + 3 years of possible extension. Geographical focus Italy. Possibility of investing also in the rest of Europe and Israel Target focus SME with high growth potential Investment stage Early Stages (start-up), Development capital Size of single investment Typically between 0,5–3,0 € Mln. Maximum size is 20% of total commitment Duration of investment Flexible (typically between 3 and 10 years) Type of investment Minority investment, co-investments with other VC or industrial partners

7. Igea’s traditional business is focused on a variety of products in orthopaedics, aimed at restoring injured cartilage and bone as well as in the field of ultrasound diagnostic . • In addition to that, Igea has recently developed a new machine called Cliniporator allowing effective therapy of certain skin cancers through a minimally-invasive surgical technique called "electroporation”, whereby the cell membrane gets permeated by electric pulses aimed at maximizing the action of chemotherapy. The Cliniporator is already in use in some of the major oncological centers in Italy and abroad. • The company expects to consolidate the electroporation business in Italy and to develop it in the major European countries with ambitious goals of profitability and revenue growth (with revenues in 2007 totalling approximately € 5 million). Igea  is also pursuing additional applications of the electroporation onto other types of non-skin cancer (also through international collaborations). www.igea.it

8. Silicon Biosystems is a medical technology company that has developed an innovative platform – comprising of a processing equipment, a software and a kit of consumable assays and reagents – for the manipulation, extraction and downstream genetic analysis of rare cells. The company benefits from a multi-disciplinary team of highly qualified engineers and biologists, led by two of the original founders and by senior managers with extensive experience in multi-national companies in the pharmaceutical and microelectronics sectors. • The main applications of the platform, that are currently pursued by Silicon Biosystems, are: • Non-invasive oncology diagnostics: extraction of circulating tumour cells from peripheral blood samples and downstream genetic analysis to identify and provide personalised treatment of tumours; • Non-invasive pre-natal diagnostics: extraction of circulating fetal cells from a peripheral blood sample and downstream genetic analysis, avoiding all risks associated with amniocentesis; • Advanced R&D : manipulation and extraction of individual cells from large samples of  cells (including living cells) for a variety of research and development purposes in the pharmaceutical, medical and biological areas. www.siliconbiosystems.com

9. Tethis S.p.A. was founded in 2004 as a spin-off of the University of Milan by a team of researchers under the guidance of Paolo Milani, The company searches for and develops nanopowders and nanocoatings for applications in various fields such as diagnostics, environmental monitoring and telecommunications. The company began collaborating with leading Italian and international firms to develop new products based on the proprietary technologies of Tethis S.p.A. in the years immediately following its foundation. Today the company’s primary focus is developing and marketing the microFIND™ diagnostic device. www.tethis-lab.com

10. YOGITECH SpA, is a Pisa based company, founded in 2000 and specialized in the development of hardware and software solutions to guarantee functional safety of electronic systems for safety critical applications, such as power steering, braking systems, airbag and other active and passive safety systems for automotive, industrial automation, railways, and medical devices. • Yogitech has several years of experience in the application of functional safety standards for electronic systems and, as member of the major standardization bodies, has a a key role in the definition of the requirements for integrated circuits such as system-on-chips, microcontrollers, analog/digital ASICs, and FPGA. • Yogitech developed a design methodology and a set of products that allow the development of electronic systems fully compliant to functional safety standards, with a strong competitive advantage in terms of cost and performance with respect to alternative technologies. www.yogitech.com

11. Main characteristics Size Euro25 Mln subscribed in equal share by IMI Investimenti S.p.A and the Italian Department for Innovation (DIT) Start 2009 Duration 10 years Geographical focus Abruzzo, Molise, Campania, Puglia, Basilicata, Calabria, Sardegna e Sicilia Target focus Companies with innovative products or processes involving digital technology Investment stage Early Stages (start-up) for at least 60% of the fund, Development capital Single investment size Less than 2,5 mln Duration of investment period 4 years Type of investments Equity, convertible notes

12. AdmantxSpA, is a spin off from Expert System SpA, leader in the field of semantic analysis of texts. Admantx is located in Naples and develops software solutions to improve performance of online advertisement. • Starting from a semantic analysis of an online page, Admantx offers the possibility of matching an ad that best fits the content and the emotions expressed in the text, without falling in the typical mistakes of keyword based analysis which is not able to accurately disambiguate the meaning of the texts. • Furthermore, the capability of capturing content and emotions will allow creative and targeted ad campaigns without the need of using cookies. • The software platform has been developed and tested with potential clients and next steps are product refinement, enlargement of the R&D and commercial team, and the beginning of commercialization of the solution in Italy, US and UK.

13. Samares SpA is based in Sesto S.G., Navacchio and Lecce (Italy). The company was established in 2008 with the purpose of addressing the energy market through Osiride, a customized HW & SW platform specifically designed for power plants and production plants performance management. • Samares provides solutions to renewable energy power plants (mainly from photovoltaic -PV-) as well as to energy consuming organizations (i.e.: production plants, large retailers, infrastructures, healthcare and large commercial facilities and buildings). • Samares targets both applications with the main objective of lowering the Cost of Ownership through vendor agnostic solutions (Osiride applies to the widest spectrum of currently available transducers and machines), allowing the plant manager to intervene more effectively and promptly in the event of a failure rather than a performance impairment, ultimately optimizing operations & maintenance allocated resources. • Furthermore Osiride A+ (Samares solution specifically developed for the Energy Efficiency), enables the plant modeling and simulation in order to forecast new performances subsequently to eventual hard changes. This allows the identification and prioritization of the highest ROI investments. • SAMARES is a fast and lean organization that gathers multidisciplinary competences in the energy, ICT, TLC and electrical engineering, and on the basis of such competences SAMARES aims to become the innovation partner of those corporates that strive to achieve best production and consumption key performance indicators. • The solutions developed by SAMARES for the management of PV power plants cover more than 150MW installations, realized in cooperation with the major EPC players in the Italian market. 13

14. Pantea is a mobile advertising and mobile marketing technology solution provider. • The company, founded in 2008 by Gaetano Liggieri (a  former Telecom Italia Mobile executive) has developed two distinct but complementary platforms: a mobile ad server and a mobile marketing platform. • Among Pantea’s clients there are some of the most dynamic operators in the mobile advertising space, such as NeomobileS.p.A., the mobile commerce and entertainment group, as well as some top brands. These companies use the Pantea platform to handle their mobile ad business or their direct –to-customer mobile communication initiatives. • The investment from Atlante Ventures Mezzogiorno will provide financial resources for the sales network development and allow the roll out of new products and functionalities onto the platform. In particular, an IT centre has been established in Catania (Sicily) to manage the company’s key accounts and develop the IT infrastructure.

15. Spinvector is start up dealing with the development of 3D solutions for videogames, augmented reality and other entertainment applications • The company was founded in 2004 by the developers of Dronez, a videogame that sold over 1 milion copies • The investment from Atlante Ventures Mezzogiorno will provide financial resources to complete the development of augmented reality solutions for B2B market and to establish sales organization 15

16. Main characteristics Atlante Seed Size Euro5 Mln (possibility to increase to 10 Mln) subscribed entirely by IMI Investimenti S.p.A Start 2011 Duration 12 years Geographical focus Italy with possibility of investing abroad Target focus Start ups with high growth potential Business incubators Investment stage Seed capital Single investment size 100k-500k for start ups, 500k-1mln for incubators Duration of investment period 5 years Type of investments Equity, convertible notes

17. Atlante Seed Investment strategy Atlante Seed €5 mln 30/50 % 50/70 % Business incubators (H Farm, M31 , ...) Start Ups • Seed capital investments require extremely specifc competences • Our strategy: co-investing with specialized operators (business incubators) • Atlante Seed will also invest in the incubators to help them start new initiatives and follow up on the most promising projects

18. Atlante Seed • H-Farm is a business incubator focused on digital media start ups • H-Farm started in 2005 and its main HQ are outside Venice, with offices also in Seattle, London, and Mumbay • H-farm provides capital and mentorship to the incubated companies allowing them large international visibiity from their beginning • Notable success stories are: H-Art, H-Care, Zooppa, H-Umus • Within H-farm there are aso two important schools: Bigrock (focused on 3D rendering technologies) and the Digital Academia (focused on digital business)

19. Atlante Ventures Imi Fondi Chiusi SGR SpA Corso Matteotti 1 – 20121 Milan, Italy E-mail:atlanteventures@intesasanpaolo.com

20. From a EU perspective, VC in Italy is poised for strong growth to catch up with its peers (D, FR, ES) Amounts invested in early stage Amount (Euro Mln) Number of investments Source: AFIC, AIFI-PwC, ASCRI, BVCA, BVK

21. Our governance leverages the ties with ISP Group while ensuring the required indipendence by the SGR legal structure INTESA SANPAOLO Div. Corporate&Investment Banking Gaetano Micciché Direzione Merchant Banking Marco Cerrina Feroni 100% IMI Investimenti S.p.A. (Bologna) 100% Imi Fondi Chiusi SGR (Bologna) Fabio Borsoi Comitato di Investimento Advisory Committee ATLANTE VENTURES ATLANTE PRIVATE EQUITY ATLANTE VENT.MEZZOG. ATLANTE SEED Team Venture Capital Davide Turco